125 related articles for article (PubMed ID: 10640431)
21. A multiphase model describing vascular tumour growth.
Breward CJ; Byrne HM; Lewis CE
Bull Math Biol; 2003 Jul; 65(4):609-40. PubMed ID: 12875336
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases.
Chantrain CF; Henriet P; Jodele S; Emonard H; Feron O; Courtoy PJ; DeClerck YA; Marbaix E
Eur J Cancer; 2006 Feb; 42(3):310-8. PubMed ID: 16406506
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis in malignant tumors.
Sarcević B
Acta Med Croatica; 2001; 55(4-5):187-90. PubMed ID: 12398022
[TBL] [Abstract][Full Text] [Related]
24. A deterministic model of growth factor-induced angiogenesis.
Sun S; Wheeler MF; Obeyesekere M; Patrick CW
Bull Math Biol; 2005 Mar; 67(2):313-37. PubMed ID: 15710183
[TBL] [Abstract][Full Text] [Related]
25. Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999).
d'Onofrio A; Gandolfi A
Math Biosci; 2004 Oct; 191(2):159-84. PubMed ID: 15363652
[TBL] [Abstract][Full Text] [Related]
26. Disruption of endothelial cell interactions with the novel HU177 cryptic collagen epitope inhibits angiogenesis.
Cretu A; Roth JM; Caunt M; Akalu A; Policarpio D; Formenti S; Gagne P; Liebes L; Brooks PC
Clin Cancer Res; 2007 May; 13(10):3068-78. PubMed ID: 17505010
[TBL] [Abstract][Full Text] [Related]
27. Understanding angiogenesis and its clinical applications.
Suh DY
Ann Clin Lab Sci; 2000 Jul; 30(3):227-38. PubMed ID: 10945562
[TBL] [Abstract][Full Text] [Related]
28. Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis.
Crivellato E; Nico B; Ribatti D
Cancer Lett; 2008 Sep; 269(1):1-6. PubMed ID: 18450371
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis.
Gottfried E; Kreutz M; Haffner S; Holler E; Iacobelli M; Andreesen R; Eissner G
Scand J Immunol; 2007 Apr; 65(4):329-35. PubMed ID: 17386023
[TBL] [Abstract][Full Text] [Related]
30. Critical conditions for pattern formation and in vitro tubulogenesis driven by cellular traction fields.
Namy P; Ohayon J; Tracqui P
J Theor Biol; 2004 Mar; 227(1):103-20. PubMed ID: 14969709
[TBL] [Abstract][Full Text] [Related]
31. The role of mechanical host-tumour interactions in the collapse of tumour blood vessels and tumour growth dynamics.
Araujo RP; McElwain DL
J Theor Biol; 2006 Feb; 238(4):817-27. PubMed ID: 16384586
[TBL] [Abstract][Full Text] [Related]
32. Role of hematopoietic lineage cells as accessory components in blood vessel formation.
Takakura N
Cancer Sci; 2006 Jul; 97(7):568-74. PubMed ID: 16827795
[TBL] [Abstract][Full Text] [Related]
33. Tumour vasculature as a target for anticancer therapy.
Eatock MM; Schätzlein A; Kaye SB
Cancer Treat Rev; 2000 Jun; 26(3):191-204. PubMed ID: 10814561
[TBL] [Abstract][Full Text] [Related]
34. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Hicklin DJ; Ellis LM
J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
36. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
Rak J; Milsom C; Yu J
APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
[TBL] [Abstract][Full Text] [Related]
37. [Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects].
Vacca A; Ribatti D; Pellegrino A; Dammacco F
Ann Ital Med Int; 2000; 15(1):7-19. PubMed ID: 10842887
[TBL] [Abstract][Full Text] [Related]
38. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis.
Scarpino S; D'Alena FC; Di Napoli A; Ballarini F; Prat M; Ruco LP
J Pathol; 2003 Feb; 199(2):243-50. PubMed ID: 12533838
[TBL] [Abstract][Full Text] [Related]
39. The vascular network of tumours--what is it not for?
Sivridis E; Giatromanolaki A; Koukourakis MI
J Pathol; 2003 Oct; 201(2):173-80. PubMed ID: 14517833
[TBL] [Abstract][Full Text] [Related]
40. Are tumours angiogenesis-dependent?
Verheul HM; Voest EE; Schlingemann RO
J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
